Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Receivables - Net (2020 - 2025)

Historic Receivables - Net for Cellebrite DI (CLBT) over the last 5 years, with Q4 2024 value amounting to $82.4 million.

  • Cellebrite DI's Receivables - Net rose 658.61% to $82.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $82.4 million, marking a year-over-year increase of 658.61%. This contributed to the annual value of $82.4 million for FY2024, which is 658.61% up from last year.
  • Cellebrite DI's Receivables - Net amounted to $82.4 million in Q4 2024, which was up 658.61% from $77.3 million recorded in Q4 2023.
  • In the past 5 years, Cellebrite DI's Receivables - Net registered a high of $82.4 million during Q4 2024, and its lowest value of $66.3 million during Q4 2020.
  • Moreover, its 5-year median value for Receivables - Net was $77.3 million (2023), whereas its average is $74.4 million.
  • As far as peak fluctuations go, Cellebrite DI's Receivables - Net surged by 1667.43% in 2022, and later tumbled by 189.43% in 2023.
  • Quarter analysis of 5 years shows Cellebrite DI's Receivables - Net stood at $66.3 million in 2020, then grew by 1.78% to $67.5 million in 2021, then grew by 16.67% to $78.8 million in 2022, then decreased by 1.89% to $77.3 million in 2023, then rose by 6.59% to $82.4 million in 2024.
  • Its last three reported values are $82.4 million in Q4 2024, $77.3 million for Q4 2023, and $78.8 million during Q4 2022.